AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sefglip M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Meditune Healthcare Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Sefglip M 500mg/50mg Tablet

Diabex Duo 500mg/50mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications, such as renal impairment and vision loss, and may lessen the risk of cardiovascular events. Diabex Duo may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy necessitates adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose readings, and existing medications. Consuming the tablets with meals minimizes gastrointestinal discomfort. Consistent daily intake, at the same time each day, maximizes therapeutic benefits; discontinuation should only occur under medical supervision. This medication actively regulates blood sugar and prevents future health problems. Continued commitment to your prescribed diet and exercise regimen is crucial. Lifestyle choices significantly impact diabetes management. Commonly reported side effects include diarrhea, nausea, vomiting, dyspepsia, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when used concurrently with insulin or sulfonylureas; appropriate recognition and management strategies are essential. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women require medical consultation before use. Drug interactions are possible; a complete medication list should be provided to your doctor to ensure safety. Alcohol should be limited due to its hypoglycemic effects. Your physician will monitor renal function and blood glucose levels throughout the treatment course.

Uses of Sefglip M 500mg/50mg Tablet

Managing Type 2 Diabetes

Major Benefits of Sefglip M 500mg/50mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sefglip M 500mg/50mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Sefglip M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Sefglip M 500mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Sefglip M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sefglip M 500mg/50mg Tablet works:

Each Sefglip M 500mg/50mg tablet combines two distinct antidiabetic medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sefglip M 500mg/50mg Tablet with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Sefglip M 500mg/50mg tablets during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sefglip M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sefglip M 500mg/50mg tablets. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Sefglip M 500mg/50mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sefglip M 500mg/50mg Tablet :

Should you forget to take your Sefglip M 500mg/50mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid doubling the prescribed dosage.

Facts to Know About Sefglip M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sefglip M 500mg/50mg Tablet

Sefglip M 500mg/50mg Tablet rarely causes hypoglycemia by itself; however, low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. These are more likely if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Sefglip M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Do not take other medications without consulting your doctor.
Sefglip M 500mg/50mg Tablet is contraindicated in patients allergic to any of its components or excipients. It should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sefglip M 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated in individuals under 18 years old.
Sefglip M 500mg/50mg Tablet can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sefglip M 500mg/50mg Tablet and seek immediate medical attention.
Prolonged Sefglip M 500mg/50mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Sefglip M 500mg/50mg Tablet as directed by your doctor is safe. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia, especially with insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Sefglip M 500mg/50mg Tabl...
119
MRP 145
17% off